Mounjaro for Weight Loss and Type 2 Diabetes
Mounjaro (tirzepatide) is indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. It is also approved for the treatment of adults with type 2 diabetes mellitus to improve glycemic control, alongside diet and exercise.
Mounjaro is a once-weekly injection that mimics the action of both GLP-1 and GIP hormones, helping to regulate appetite, glucose levels, and food intake, resulting in significant weight loss.
Basic Details
How to use
Basic Details
| Type of Medicine | A dual GLP-1 and GIP receptor agonist |
|---|---|
| Used for | Chronic weight management and management of type 2 diabetes in adults |
| Also called | Tirzepatide |
| Available as | Injections |
How to use
Mounjaro (Tirzepatide) helps achieve an average weight loss of approximately 20% by reducing appetite and increasing feelings of fullness, which leads to decreased caloric intake. It is used as part of a comprehensive treatment program that includes lifestyle changes like diet and exercise.What is Tirzepatide available as?
- Injections: Available in a single pen containing doses for 4 weeks.
Registered with the GPhC and MHRA, we strive to provide a reliable, cost-effective service to our patients and customers.